Clinical trials

  • IVONESCIMAB for Gastric adenocarcinoma | Esophagogastric junction adenocarcinoma
  • ETENTAMIG for Multiple myeloma
  • LACTOBACILLALES for Multiple sclerosis|Relapsing-remitting multiple sclerosis
  • RIBOCICLIB for Early breast cancer | Hormone receptor-positive breast cancer | HER2-negative breast cancer
  • ZELENECTIDE PEVEDOTIN for Advanced or metastatic non-small cell lung cancer
  • DEPEMOKIMAB for Chronic obstructive pulmonary disease
  • PETOSEMTAMAB for Non-small cell lung cancer
  • PNEUMOCOCCAL POLYSACCHARIDE CONJUGATES (multiple serotypes conjugated to CRM197) (see product record for full list of serotypes) for Community-acquired pneumonia
  • ETRASIMOD ARGININE for Ulcerative colitis
  • ZASOCITINIB for Moderately to severely active ulcerative colitis | Ulcerative colitis
  • KT-621 for Uncontrolled moderate to severe eosinophilic asthma|Eosinophilic asthma
  • BEVACIZUMAB for Barrett's esophagus|Colon carcinoma|Gastrointestinal dysplasia